About the journal
Frontiers in Nuclear Medicine is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 2673-8880
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,950 CHF
- Articles in DOAJ
- 147
- Declared review time
- 11 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.frontiersin.org/journals/nuclear-medicine
Index listings
- DOAJ · 2022-03-07
- Indexing
- DOAJ
- APC
- 1,950 CHF
- Declared review time (DOAJ)
- 11 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
147
Most recent article
last month
Average review time (journal-declared via DOAJ)
11weeks
Works in OpenAlex
235
Last recorded publication year
2026
h-index
15
i10-index
41
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2022-03-07
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918470388806676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Medical Imaging Techniques and Applications
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
Show all subjects (50)
- Medical Imaging and Pathology Studies
- Medical Imaging and Pathology Studies
- Advanced MRI Techniques and Applications
- Advanced MRI Techniques and Applications
- Cardiac Imaging and Diagnostics
- Cardiac Imaging and Diagnostics
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Prostate Cancer Treatment and Research
- Radiation Detection and Scintillator Technologies
- Radiation Detection and Scintillator Technologies
- Prostate Cancer Treatment and Research
- Radiation Dose and Imaging
- Radiation Dose and Imaging
- Advanced X-ray and CT Imaging
- Neuroblastoma Research and Treatments
- Advanced Radiotherapy Techniques
- Advanced X-ray and CT Imaging
- Neuroblastoma Research and Treatments
- Advanced Radiotherapy Techniques
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Chemotherapy-related skin toxicity
- Prostate Cancer Diagnosis and Treatment
- Chemotherapy-related skin toxicity
- Prostate Cancer Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Parathyroid Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Multiple Myeloma Research and Treatments
- Parathyroid Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Artificial Intelligence in Healthcare and Education
- Neuropeptides and Animal Physiology
- Neuropeptides and Animal Physiology
- Artificial Intelligence in Healthcare and Education
Keywords (DOAJ)
- dosimetry
- radiomics
- radionuclide therapy
- radiopharmacy
- radiation safety
- pet and spect
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ